Editorial: Glucocorticoid and bone: Friend or foe

被引:3
作者
Baschant, Ulrike [1 ,2 ]
Hauser, Barbara [3 ,4 ]
Winter, Elizabeth Martha [5 ]
机构
[1] Tech Univ Dresden, Dept Med 3, Div Endocrinol Diabet & Bone Dis, Dresden, Germany
[2] Tech Univ Dresden, Ctr Hlth Aging, Dresden, Germany
[3] Univ Edinburgh, Ctr Genom & Expt Med, Inst Genet & Canc, Edinburgh, Midlothian, Scotland
[4] Western Gen Hosp, Rheumat Dis Unit, Edingburgh, Scotland
[5] Leiden Univ, Ctr Bone Qual, Med Ctr, Dept Internal Med,Div Endocrinol, Leiden, Netherlands
来源
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
关键词
glucocorticoid; bone; osteoporosis; treatment; secondary osteoporosis;
D O I
10.3389/fendo.2022.995124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 1 条
[1]   Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial [J].
Leder, Benjamin Z. ;
Tsai, Joy N. ;
Uihlein, Alexander V. ;
Burnett-Bowie, Sherri-Ann M. ;
Zhu, Yuli ;
Foley, Katelyn ;
Lee, Hang ;
Neer, Robert M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05) :1694-1700